Literature DB >> 26416385

Phenylephrine Pharmacokinetics and First-Pass Metabolism: What Is an Ideal Pharmacokinetic Surrogate?

Nuggehally R Srinivas1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26416385     DOI： 10.1007/s40261-015-0341-3

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN： 1173-2563            Impact factor:   2.859


× No keyword cloud information.
  10 in total

1.  Dose-dependent pharmacokinetics and first-pass metabolism of acetaminophen in rats.

Authors:  Y Tone; K Kawamata; T Murakami; Y Higashi; N Yata
Journal:  J Pharmacobiodyn       Date:  1990-06

Review 2.  Recent trends in preclinical drug-drug interaction studies of flavonoids--Review of case studies, issues and perspectives.

Authors:  Nuggehally R Srinivas
Journal:  Phytother Res       Date:  2015-09-06       Impact factor: 5.878

3.  Pharmacokinetics of methyldopa in man.

Authors:  K C Kwan; E L Foltz; G O Breault; J E Baer; J A Totaro
Journal:  J Pharmacol Exp Ther       Date:  1976-08       Impact factor: 4.030

4.  Sulfation of budesonide by human cytosolic sulfotransferase, dehydroepiandrosterone-sulfotransferase (DHEA-ST).

Authors:  Connie A Meloche; Vyas Sharma; Stellan Swedmark; Paul Andersson; Charles N Falany
Journal:  Drug Metab Dispos       Date:  2002-05       Impact factor: 3.922

5.  Increased bioavailability of phenylephrine by co-administration of acetaminophen: results of four open-label, crossover pharmacokinetic trials in healthy volunteers.

Authors:  Hartley C Atkinson; Ioana Stanescu; Isam I Salem; Amanda L Potts; Brian J Anderson
Journal:  Eur J Clin Pharmacol       Date:  2014-12-06       Impact factor: 2.953

6.  Phase II metabolism of hesperetin by individual UDP-glucuronosyltransferases and sulfotransferases and rat and human tissue samples.

Authors:  Walter Brand; Marelle G Boersma; Hanneke Bik; Elisabeth F Hoek-van den Hil; Jacques Vervoort; Denis Barron; Walter Meinl; Hansruedi Glatt; Gary Williamson; Peter J van Bladeren; Ivonne M C M Rietjens
Journal:  Drug Metab Dispos       Date:  2010-01-07       Impact factor: 3.922

7.  Pharmacokinetics of 3H-phenylephrine in man.

Authors:  J H Hengstmann; J Goronzy
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

8.  Ibopamine kinetics after a single oral dose in healthy volunteers.

Authors:  E Lodola; M Borgia; A Longo; F Pocchiari; R Pataccini; D Sher
Journal:  Arzneimittelforschung       Date:  1986-02

9.  Favipiravir inhibits acetaminophen sulfate formation but minimally affects systemic pharmacokinetics of acetaminophen.

Authors:  Yanli Zhao; Jerold S Harmatz; Carol R Epstein; Yukako Nakagawa; Chie Kurosaki; Tetsuro Nakamura; Takumi Kadota; Dennis Giesing; Michael H Court; David J Greenblatt
Journal:  Br J Clin Pharmacol       Date:  2015-06-08       Impact factor: 4.335

10.  Pharmacokinetics, safety, and cardiovascular tolerability of phenylephrine HCl 10, 20, and 30 mg after a single oral administration in healthy volunteers.

Authors:  Cathy K Gelotte; Brenda A Zimmerman
Journal:  Clin Drug Investig       Date:  2015-09       Impact factor: 2.859
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.